UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-10-26 | Future report Set alerts | |
| Q2 2022 | 2022-08-02 | 0.38 | 0.38 |
| Q1 2022 | 2022-05-10 | -1.61 | -1.61 |
| Q4 2021 | 2022-02-10 | 0.06 | 0.06 |
| Q3 2021 | 2021-10-28 | 0.34 | 0.34 |
| Q2 2021 | 2021-07-29 | 0.10 | 0.10 |
| Q1 2021 | 2021-05-10 | 0.29 | 0.29 |
| Q4 2020 | 2021-02-10 | 0.44 | 0.44 |
| Q3 2020 | 2020-10-28 | 0.28 | 0.28 |
| Q2 2020 | 2020-07-30 | 0.38 | 0.38 |
| 2016-07-05 | Reiterated Rating | Pacific Crest | Sector Weight | |
| 2016-05-03 | Lower Price Target | Imperial Capital | In to In-Line | $32.00 to $29.00 |
| 2016-04-02 | Reiterated Rating | Imperial Capital | Hold | |
| 2016-04-01 | Lower Price Target | Imperial Capital | In to In-Line | $35.00 to $32.00 |
| 2016-02-04 | Lower Price Target | Wedbush | Outperform | $46.00 to $40.00 |
| 2016-01-25 | Upgrade | Northcoast Research | Neutral to Buy | |
| 2015-12-11 | Reiterated Rating | Wedbush | Outperform | $46.00 |
| 2015-11-23 | Boost Price Target | Wedbush | Outperform | $44.00 to $46.00 |
| 2015-10-19 | Reiterated Rating | Wedbush | Outperform | $40.00 to $44.00 |
| 2015-09-18 | Reiterated Rating | Wedbush | Buy | $40.00 |
| 2015-09-16 | Lower Price Target | Imperial Capital | In to In-Line | $39.00 to $35.00 |
| 2015-08-31 | Upgrade | Wedbush | Neutral to Outperform | $40.00 |
| 2015-07-31 | Upgrade | Wedbush | Neutral to Outperform | $40.00 |
| 2015-07-28 | Lower Price Target | JPMorgan Chase & Co. | Neutral | $39.00 to $36.00 |
| 2015-07-22 | Initiated Coverage | Alembic Global Advisors | Overweight | |
| 2015-06-12 | Boost Price Target | Wedbush | Neutral | $36.00 to $40.00 |
| 2015-06-04 | Upgrade | JPMorgan Chase & Co. | Underweight to Neutral | $33.00 to $39.00 |
| 2015-04-07 | Boost Price Target | KeyBanc | Overweight | $38.00 to $40.00 |
| 2015-04-07 | Boost Price Target | KeyCorp | Overweight | $38.00 to $40.00 |
| 2014-11-03 | Reiterated Rating | Imperial Capital | In-Line | $37.00 to $39.00 |
| 2014-03-03 | Boost Price Target | Wedbush | $35.00 to $38.00 | |
| 2014-02-13 | Boost Price Target | Susquehanna | $27.00 to $30.00 | |
| 2014-01-17 | Boost Price Target | Imperial Capital | In-Line | $33.00 to $35.00 |
| 2013-11-18 | Upgrade | KeyBanc | Hold to Buy | $35.00 |
| 2013-11-14 | Lower Price Target | Susquehanna | Neutral | $29.00 to $27.00 |
| 2013-10-15 | Downgrade | Compass Point | Neutral to Sell | $25.00 to $23.00 |
| 2013-07-11 | Reiterated | Compass Point | Neutral | $26 to $31 |
| 2013-04-30 | Reiterated | Compass Point | Neutral | $30 to $26 |
| 2013-02-14 | Reiterated | Imperial Capital | Outperform | $36 to $35 |
| 2013-01-24 | Reiterated | Compass Point | Neutral | $33 to $30 |
| 2012-06-21 | Initiated | Imperial Capital | Outperform | $47 |
| 2012-04-24 | Upgrade | Compass Point | Neutral to Buy | $40 to $45 |
| 2010-11-22 | Reiterated | Wedbush | Neutral | $30 to $33 |
| 2010-06-29 | Reiterated | Wedbush | Neutral | $34 to $30 |
| 2010-04-16 | Downgrade | KeyBanc Capital Mkts | Buy to Hold |
| 2016-07-05 | Reiterated Rating | Pacific Crest | Sector Weight | |
| 2016-05-03 | Lower Price Target | Imperial Capital | In to In-Line | $32.00 to $29.00 |
| 2016-04-02 | Reiterated Rating | Imperial Capital | Hold | |
| 2016-04-01 | Lower Price Target | Imperial Capital | In to In-Line | $35.00 to $32.00 |
| 2016-02-04 | Lower Price Target | Wedbush | Outperform | $46.00 to $40.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In DBD 151 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Inc. | 11.19M |
| Vanguard Group, Inc | 5.86M |
| BlackRock Fund Advisors | 4.40M |
| GAMCO INVESTORS, INC. ET AL | 3.30M |
| Beach Point Capital Management LP | 3.23M |
| STATE STREET CORP | 2.59M |
| D. E. Shaw & Co., Inc. | 2.57M |
| Ancora Advisors, LLC | 2.34M |
| BlackRock Institutional Trust Company, N.A. | 2.17M |
| Invesco Ltd. | 1.69M |
| Neuberger Berman Group LLC | 1.56M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.27M |
| RUSSELL FRANK CO/ | 1.14M |
| MORGAN STANLEY | 1.12M |
| CITADEL ADVISORS LLC | 1.10M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Mattes Andreas W President and CEO | 0.32% (209590) | DBD / |
| SWIDARSKI THOMAS W President & CEO | 0.25% (163054) | AIMC / DBD / EFOI / EVTC / |
| Schmid Gerrard President and CEO | 0.18% (117245) | DBD / |
| Mayes George S JR EVP & Chief Operating Officer | 0.12% (77863) | DBD / SRI / |
| Chapman Christopher A. Vice President, Global Finance | 0.11% (71829) | DBD / |
| FITZGERALD GALE S | 0.10% (61531) | CCRN / DBD / HNT / |
| CRANDALL RICHARD L | 0.08% (53281) | DBD / DFIN / RRD / |
| WALLACE HENRY D G | 0.08% (49114) | AMBC / DBD / LEA / |
| WEBER ALAN J | 0.07% (47942) | BR / DBD / SD / |
| Leiken Jonathan SVP, CLO and Secretary | 0.07% (42521) | DBD / |
| LAUER JOHN N | 0.06% (39048) | DBD / |
| Wunram Jurgen SVP, Chief Integration Officer | 0.06% (37457) | DBD / |
| ALLENDER PATRICK W | 0.06% (36442) | BRC / CFX / DBD / |
| COX PHILLIP R | 0.06% (35642) | CBB / DBD / TKR / |
| KERR ALAN SVP, Software | 0.05% (34387) | DBD / |
| SOIN RAJESH K | 0.05% (33742) | DBD / |
| Rutt Sheila M VP, Chief HR Officer | 0.05% (33023) | DBD / |
| RICHARDSON BRADLEY C EVP & CFO | 0.05% (32741) | BRC / DBD / POL / TROX / |
| GREENFIELD GARY G | 0.04% (26292) | AVID / DBD / DFIN / VOCS / |
| Heyden Olaf Robert SVP, Services | 0.04% (25362) | DBD / |
| Naher Ulrich SVP, Systems | 0.04% (25362) | DBD / |
| Natoli Frank A EVP, Chief Innovation Officer | 0.04% (22629) | DBD / |
| Merz Stefan Sr. VP, Strategic Projects | 0.04% (22627) | DBD / |
| PRATHER ROBERT S JR | 0.03% (20564) | DBD / GBL / GTN / RHP / |
| Kristoff John D VP, Chief Communications Ofcr. | 0.03% (19838) | DBD / |
| Lang Patricia A VP and Chief People Officer | 0.03% (18014) | DBD / |
| BYRNES BRUCE L | 0.02% (16112) | BSX / CBB / DBD / |
| Dusedau Dieter | 0.02% (15092) | DBD / |
| Dibelius Alexander | 0.02% (15092) | DBD / |
| Hunter Matthew Scott VP Treasurer Chief Tax Officer | 0.02% (14853) | DBD / |
| Brown Dean Alexander VP, Corp Strategy & Developmt | 0.02% (11914) | DBD / |
| Hesse Chad F VP General Counsel & Secretary | 0.02% (11190) | DBD / |
| Macey Christopher VP, Corporate Controller | 0.02% (10244) | AIT / DBD / |
| Artavia Roberto | 0.01% (7362) | DBD / |
| Deering Dennis D. VP Global Service & Operations | 0.01% (5501) | DBD / |
UM